Compare Citius Pharmaceuticals Inc (CTXR) vs Noble Corporation plc (NE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Noble Corporation plc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Noble Corporation plc trades at $44.25 (market cap $7.10B). The key difference: Noble Corporation plc is far larger — about 354.8× Citius Pharmaceuticals Inc's market cap, and Noble Corporation plc pays a 4.5% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | NE | |
|---|---|---|
Market Cap | $20.01M | $7.10B |
Sector | Health | Technology |
52-Week High | $1.82 | $54.37 |
52-Week Low | $0.48 | $26.61 |
Enterprise Value | $16.23M | $8.53B |
Dividend Yield | — | 4.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
